• Publications
  • Influence
Cognitive-Behavioral Group Therapy for Social Phobia: Basic Mechanisms and Clinical Strategies
Part I: Understanding the Nature of Social Phobia. The Diagnosis and Etiology of Social Phobia. Subtypes of Social Phobia, Comorbidity, and Impairment. Cognitive Function in Social Phobia.Expand
  • 342
  • 19
Cognitive behavioral group treatment for social phobia: Comparison with a credible placebo control
Forty-nine patients participated in a study comparing cognitive-behavioral group treatment (CBGT) for social phobia with a credible placebo control. CBGT consisted of exposure to simulated phobicExpand
  • 301
  • 16
DSM-III-R Subtypes of Social Phobia: Comparison of Generalized Social Phobics and Public Speaking Phobics
Social phobic patients who fear most or all social interaction situations are labeled generalized social phobics in DSM-III-R. Thirty-five patients who met this criterion were compared with 22 socialExpand
  • 253
  • 4
Evaluation of the Social Interaction Self-Statement Test with a social phobic population
The convergent and discriminant validity of the Social Interaction Self-Statement Test (SISST) were evaluated in a sample of men and women awaiting treatment for fear and avoidance of socialExpand
  • 64
  • 4
Anxiety disorders, depression, and attributional style: A further test of the specificity of depressive attributions
This study examined the specificity to depression of the attributional style hypothesized by the reformulated model of learned helplessness. Scores on a modified version of the Attributional StyleExpand
  • 35
  • 4
Lost in Translation: Neuropsychiatric Drug Development
The sluggish pace of development of new drugs for neuropsychiatric diseases can be attributed in part to faulty clinical trial design. Clearing the Logjam in Neuropsychiatry The drugs available toExpand
  • 42
  • 3
Diagnosis of secondary depression in schizophrenia.
Four diagnostic groups were studied to determine the relationship of depression secondary to schizophrenia to DSM-III major depression criteria and Hamilton Depression Rating Scale scores. TheExpand
  • 55
  • 3
Determination of physostigmine in plasma and cerebrospinal fluid by liquid chromatography with electrochemical detection.
Physostigmine (Phy) was determined in plasma and cerebrospinal fluid (CSF) by HPLC with electrochemical detection, with use of a normal-phase column and methanolic sodium acetate buffer, pH 4.6. TheExpand
  • 14
  • 2
One hundred years after the discovery of Alzheimer's disease. A turning point for therapy?
Following the introduction of cholinesterase inhibitors in 1986 and a 20-yr long period of successful clinical application in mild, moderate and severe patients, the treatment of AD has turned toExpand
  • 88
  • 2
The Second Generation of Cholinesterase Inhibitors: Clinical and Pharmacological Effects
One potentially important and widely studied approach to cholinomimetic therapy in Alzheimer disease (AD) is the use of substances that inhibit acetylcholinesterase (AChE). Acetylcholinesterase isExpand
  • 54
  • 2